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Abstract
Development of right ventricular (RV) failure in patients after ST-segment 
elevation myocardial infarction (STEMI) is common. However, a systematic 
analysis of chamber-specific changes in the expression of genes linked to cardiac 
function, apoptosis, fibrosis, receptor responsiveness, and inflammation is lacking. 
Postischemic remodeling was analyzed in rats that received STEMI in the closed 
chest mode. Rats were sacrificed at day 1, 3, 7, and 120 after surgery. The mRNA 
expression of genes was quantified by a real-time RT-PCR. Echocardiography 
was performed after 120 days. Organ weights and systemic blood pressure were 
determined in addition. Rats developed left and RV dysfunction within 7 days after 
ischemia/reperfusion and this lasted until the end of the experiments. However, 
adaptation to ischemia/reperfusion differed significantly between both ventricles. 
In the LV, a high expression of MMP12, a neutrophile-specific elastase, indicated a 
significant inflammatory responsiveness that did not occur in RV. A number of dif-
ferentially regulated genes in the RV exceeded that of the LV at day 3. Postinfarction 
RV failure is common in rats with ischemia/reperfusion of the left arterial descend-
ing aorta. It is associated with severe RV remodeling that occurred delayed to that 
of the LV. Changes in RV are independent of the initial inflammation.
Keywords: myocardial infarction, cardiac remodeling, right heart failure, 
inflammation, reperfusion injury
1. Introduction
Right ventricular (RV) failure is common in patients with acute ST-segment 
elevated myocardial infarction (STEMI) and animal models of remodeling post-
myocardial infarction [1–3]. The underlying reason for biventricular failure due 
to myocardial infarction and/or transient ischemic events is not clear but may be a 
consequence of hemodynamic changes during infarction and ischemic events in the 
RV as well. Nevertheless, RV failure is a severe complication during the subsequent 
postinfarct period and a limitation of further prognosis [4]. Therefore, it is impor-
tant to understand the molecular adaptation of the RV in response to LV infarction.
Molecular and cellular mechanisms involved in cardiac remodeling after myo-
cardial infarction are triggered by transcriptional regulation of genes linked to 
apoptosis, fibrosis, inflammation, calcium handling, and receptor responsiveness. 
Some of these adaptive mechanisms occur early after reperfusion and activation 
of the transcription factor AP-1 have been identified as main factors [5]. However, 
steady-state mRNA levels depend also from RNA degradation leading to a decrease 
in the expression of some genes. Thus, steady-state mRNA expression of genes 
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involved in cardiac remodeling can be increased or decreased. Real-time RT-PCR 
allows quantification of such molecular and cellular adaptation in tissues and can be 
used to characterize such changes in a time- and organ-specific manner. This study 
was aimed to identify differentially regulated cardiac genes in the LV and RV that 
are involved in cardiac remodeling during postmyocardial infarction.
The left anterior descending coronary artery was occluded in rats for 45 min and 
subsequently reopened. Success of occlusion and reperfusion was monitored by 
ECG recordings. Rats were sacrificed after 1, 3, 7, and 120 days and the left and right 
ventricles were removed and analyzed thereafter. The hemodynamic consequences 
were recorded by echocardiography.
2. Material and methods
2.1 Animal models and animal handling
The investigation conforms to the directive 2010/63/EU of the European 
Parliament. Use of animals was registered at the Justus-Liebig-University (registra-
tion-no.: 417-M). The experimental protocols were approved by the ethics commit-
tee for animal experimentation of the local authorities in Giessen, Germany and 
Szeged, Hungary.
Myocardial infarction and reperfusion was performed in the closed-chest model. 
To achieve this, rats were anesthetized by inhalation of isoflurane (induction: 
5%, maintenance: 2–3%), intubated, and placed on a respirator during surgery to 
maintain ventilation. Before surgery, 0.03 mg/kg nalbuphine (Nalbuphin Orpha, 
AOP Orpha Pharmaceuticals, Vienna, Austria) was injected (i.p.). The adequacy 
of anesthesia was monitored by electrocardiography and pulse rate. A suture was 
placed around the left anterior descending coronary artery (LAD) and remained 
subcutaneously [6]. Two hours after the wound closing, 0.03 mg/kg nalbuphine 
was repeated to alleviate postoperative pain. Seven days later, rats were anesthetized 
as before and the suture was mobilized and the LAD was occluded for 30 min. 
The occlusion was monitored by electrocardiography (ST elevation; see Figure 1). 
Thereafter, the occluder was opened again and the suture was cut and the skin was 
closed in one layer. Sham rats received the same protocol but the occluder was not 
mobilized after 7 days. Please note that this study is a second end-point analysis 
of tissue material also used before to characterize the role of arginase in ischemia/
reperfusion injury [7].
2.2 Ex vivo analysis of cardiac function
In order to analyze the cardiac function ex vivo, rats were anesthetized again 
by isoflurane and killed by cervical dislocation. Thereafter, hearts were rapidly 
excised and the aorta was cannulated for retrograde perfusion with a 16-gauge 
needle connected to a Langendorff perfusion system. Left ventricular function was 
determined by insertion of a water-filled balloon into the left ventricle as described 
before [8]. Hearts were paced during measurements.
2.3 In vivo analysis of cardiac function
Transthoracic echocardiography was performed as described previously [9] 
under isoflurane anesthesia (1.5%) at 120 days after ischemia/reperfusion. Briefly, 
two-dimensional and M-mode echocardiographic examinations were performed 
in accordance with the criteria of the American Society of Echocardiography with 
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a Vivid 7 dimension ultrasound system (General Electric Medical Systems) using a 
phased array 5.5–12 MHz transducer (10S probe). Data of three consecutive heart 
cycles were analyzed (EchoPac Dimension software; General Electric Medical 
Systems) by an experienced investigator in a blinded manner. The mean values of 
three measurements were calculated and used for statistical evaluation. Functional 
parameters including left ventricular ejection fraction (EF) and fractional shorten-
ing (FS) were calculated on four-chamber view images.
2.4 qRT-PCR
After removing the hearts from the Langendorff apparatus, the ventricular 
tissue was carefully isolated and quickly frozen into fluid nitrogen. Tissue samples 
were prepared to analyze the steady-state mRNA levels of proteins of interest 
according to the previously described method [8]. Briefly, total RNA was iso-
lated from the ventricles using peqGoldTriFast (peqlab, Biotechnology GmbH, 
Germany) according to the manufacturer’s protocol. To remove genomic DNA 
contamination, isolated RNA samples were treated with 1 U DNase per mg RNA 
(Invitrogen, Karlsruhe, Germany) for 15 min at 37°C. One microgram of total 
RNA was used in 10 μl reaction to synthesize cDNA using superscript RNaseH 
Figure 1. 
ECG recording during ischemia (A) and after reperfusion (B) indicating ST elevation in these rats  
(red arrow). (C) TTC staining visualizing the location of the infarct.
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Forward Reverse
ANP ATG GGC TCC TTC TCC ATC AC TCT TCG GTA CCG GAA GCT
BNP ATG ATT CTG CTC CTG CTT TTC TCT GCA TCG TGG ATT GTT CTG
MHC-α CAC CCT GGA GGA CCA GAT TA TGG ATC CTG ATG AAC TTC CC
TGF-β1 ATT CCT GGC GTT ACC TTG G CCT GTA TTC CGT CTC CTT GG
Biglycan TGA TTG AGA ATG GGA GCC TGA G CCT TGG TGA TGT TGT TGG AGT G
Decorin GGC AGT CTG GCT AAT GTT C CTT CGG AGA TGT TGT TGT TAT G
Collagen-1 GCG AAC AAG GTG ACA GAG CCA GGA GAA CCA GCA GAG
Collagen-3 TGG AGT CGG AGG AAT G GCC AGA TGG ACC AAT AG
Elastin TGC TAC TGC TTG GTG GAG AAT G CGT GGC TGC TGC TGT CTG
Fibronectin TGG AGC AAG AAG GAC AAC CGG ACA TCT GTG AAG GAG
Laminin CGA GGA TGT CAG CGT TGT TCA CAG CCG TCT CCA GTC
SERCA2a CGA GTT GAA CCT TCC CAC AA AGG AGA TGA GGT AGC GGA TGA A
Phospholamban TAT GTC TGC TGC TGA TAT GC ACT CTT AAA TCG TGA CCC TTC
NCX CGC TAA TCA GCA TTT CAG AG GCC AGG TTC GTC TTC TTA AT
Bax ACT AAA GTG CCC GAG CTG ATC CAC TGT CTG CCA TGT GGG G
Bcl-2 ATC TTC TCC TTC CAG CCT GA TCA GTC ATC CAC AGA GCG AT
ODC GAA GAT GAG TCA AAC GAG CA AGT AGA TGT TTG GCC TCT GG
Arginase-2 TGA GGA GCA GCG TCT CCC GT GCT TCT CGG ATG GCG GCT GG
eNOS AGC CCG GGA CTT CAT CAA TCA G GCC CCA AAC ACC AGC TCA CTC TC
Intermedin TGC CTC AGG GTG GTG GCT CAA CT GTG GGG GCT GCT GGG AT
RAMP-1 AGC ATC CTC TGC CCT TTC ATT GAC CAC CAG GGC AGT CAT G
RAMP-2 GCA GCC TAC CTT CTC CGA TCC TCC TCC ACA CCA CAA GCG TAA C
RAMP-3 CAA CCT GTC GGA GTT CAT CGT TGT CTC CAT CTC CGT GCA GTT
MMP9 CAA TCC TTG CAA TGT GGA TG AAA TCT TCT TGG ACT GCG GA
MMP12 TGC AGC TGT CTT TGA TCC AC GCA TCA ATT TTT GGC CTG AT
iNOS AAG AGA CGC ACA GGC AGA G CAG CAG GCA CAC GCA ATG
Nrf-1 GGC ATC ACT GGC AGA GGC CG GCT GCT GCG GTT TCC CCA GA
PGC-1α AGT GCT CAG CCG AGG ACA CGA TGC CCC TGC CAG TCA CAG GA
SDF-1α CCA AGG TCG TCG CCG TGC TG GGC TCT GGC GAC ATG GCT CT
VEGF TGC CCC TAA TGC GGT GTG CG GGC TCA CAG TGA ACG CTC CAG G
GATA4 CTA TGG CCG CCA ACC ACG GG CGC GGA GTG GGC ACG TAG AC
Mef-2c CAG TTG GGA GAC CGT ACC AC GTG AGT CCA ATG GGG GAG TG
Nkx.2a CAC ACG CCC TCC TCA GTC AA GAG TAG CCG TCC GGC TTG AA
vWF AAG ATG GCA AGA GAG TGG GC CCG TAG GCC TCA CTG GAA AG
VE-cadherin CCA GAA TTT GCC CAG CCC TA GTC CTC GTT CTT CAG GGC AA
B2M GCC GTC GTG CTT GCC ATT C CTG AGG TGG GTG GAA CTG AGA C
HPRT CCA GCG TCG TGA TTA GTG AT CAA GTC TTT CAG TCC TGT CC
Table 1. 
List of primers used in this study.
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reverse transcriptase (200 U/μg; Invitrogen) and oligo dTs (Roche, Mannheim, 
Germany) as primers. Reverse transcriptase reactions were performed for 60 min at 
37°C. Real-time PCR was performed using the Icycler IQ detection system (Bio-
Rad, Munich, Germany) in combination with IQ SYBR Green real-time supermix 
(Bio-Rad). A complete list of all primers used in this study is given in Table 1. Data 
are normalized to hypoxanthine phosphoribosyltransferase (HPRT) expression that 
was used as a house-keeping gene in this study. Preliminary experiments with β2 
microglobulin, which was alternatively considered as house-keeping gene, revealed 
similar results but higher variability. The relative change in expression was quanti-
fied by the ΔΔC method [10].
2.5 Statistics
The results are expressed as means ± S.E.M or median with 25 and 75% quartiles 
as indicated in the legend to the figures. Statistical comparisons were performed 
by two-side T-Test or Mann-Whitney Test. Levene test was used to check the 
normal distribution of the samples. A p value of 0.05 was considered as statistical 
significant.
3. Results
3.1  Weight of organs, left ventricular pressures, and biventricular functions 
analysis over time
Body weight, LV weight, RV weight, lung wet weight, and kidney weight 
increased during the 4-months observation period in sham rats and those undergo-
ing ischemia/reperfusion (Table 2). Mean increase in body weight at day 3 after 
the ischemic event was smaller in the surgery group (+2 g) versus the sham group 
(+13 g) indicating a small impact of the surgery on general behavior. Differences 
between both groups in ventricular weight occurred only for the RV at day 1 (Table 1). 
RV weights of rats in the experimental group normalized thereafter. No differences 
were obtained for lung and kidney weights (Table 2). Necrotic tissue was nearly 
exclusively seen in LV (Figure 1).
LV function was determined in vitro. Immediately after ischemia/reperfusion, 
a significant decline in cardiac function was observed but this was normalized 
thereafter (Table 3). Biventricular function was analyzed after 120 days via echo-
cardiography. RV fractional area change (four-chamber view) and LV ejection 
fraction (longitudinal four-chamber view) were significantly lower in rats of the 
experimental group compared to shams (Table 4).
3.2 Biventricular gene regulation over time
In total, biventricular expression of 36 genes was analyzed by a real-time 
RT-PCR. These genes cover the following area of interest: cardiac hypertrophy 
(ANP, BNP, MHC-α), fibrosis (TGF-β1, biglycan, decorin, collagen-1, collagen-3, 
elastin, fibronectin, laminin, MMP9), intracellular calcium handling (SERCA2a, 
phospholamban, NCX), apoptosis (bax, bcl-2), arginine metabolism  
(ODC, arginase-2, eNOS), receptor coupling (intermedin, RAMP-1, -2, -3), 
inflammation (iNOS, MMP12), cardiac metabolism (Nrf-1, PGC-1α), stem 
cell mobilization (SDF-1α, CXCR4, VEGF), cardiac transcription factors 
(GATA-4, Mef-2c, Nkx.2a), and endothelial markers (von Willebrand factor 
(vWF), VE-cadherin). Figure 2 shows how many of these 36 genes were either 
Visions of Cardiomyocyte - Fundamental Concepts of Heart Life and Disease
6
upregulated or downregulated in the two ventricles over the time. In general, 
there was an upregulation of several genes mainly at day 3 postinfarction, whereas a 
downregulation of genes dominated at days 7 and 120. At the first time point (day 1), 
BW LV/BW RV/BW Lung/BW Kidney/BW
(g) (mg/g) (mg/g) (mg/g) (mg/g)
Day 1
Sham 208 ± 28 2.76 ± 0.37 0.48 ± 0.10 8.38 ± 2.06 5.87 ± 0.65
I/R 209 ± 16 2.87 ± 0.16 0.66 ± 0.07 8.90 ± 3.01 6.94 ± 2.11
P value 0.958 0.317 0.003 0.711 0.222
Day 3
Sham 222 ± 17 2.64 ± 0.11 0.57 ± 0.06 8.14 ± 2.00 6.05 ± 0.39
I/R 211 ± 21 2.69 ± 0.22 0.64 ± 0.10 7.28 ± 0.77 5.77 ± 0.25
P value 0.292 0.550 0.135 0.674 0.133
Day 7
Sham 222 ± 20 2.69 ± 0.15 0.51 ± 0.08 7.47 ± 0.95 5.80 ± 0.36
I/R 225 ± 22 2.93 ± 0.25 0.51 ± 0.07 7.81 ± 1.43 6.03 ± 0.61
P value 0.775 0.054 1.000 0.613 0.389
Day 120
Sham 255 ± 16 2.69 ± 0.13 0.53 ± 0.06 8.84 ± 1.81 5.85 ± 0.34
I/R 256 ± 21 2.74 ± 0.52 0.55 ± 0.12 9.89 ± 1.08 6.32 ± 0.73
P value 0.908 0.736 0.666 0.211 0.210
Data are means ± S.D. from n = 8–9 rats. Data are given for body weight (BW), left ventricular weight (LV), right 
ventricular weight (RV), lung weight, and kidney weight. Data for LV, RV, lung, and kidney were normalized to body 
weight.
Table 2. 
Body weight and organ weight.
Sham I/R Δ P value
Day 1 157.5 ± 20.9 mmHg 122.9 ± 21.7 mmHg Δ = −34.6 mmHg 0.006
Day 3 155.0 ± 23.8 mmHg 132.0 ± 30.1 mmHg Δ = −23.0 mmHg 0.113
Day 7 188.2 ± 31.4 mmHg 162.1 ± 15.4 mmHg Δ = −26.1 mmHg 0.054
Day 120 144.4 ± 10.4 mmHg 137.9 ± 22.3 mmHg Δ = −6.5 mmHg 0.442
Data are means ± S.D. from n = 8–9 hearts.
Table 3. 
Left ventricular developed pressure (LVDP).
Sham I/R Δ P value
LV EF 65.0 ± 5.8 51.3 ± 8.1 Δ = −13.7% 0.000
RV FAC 55.8 ± 7.2 45.5 ± 7.2 Δ = −10.3% 0.004
Data are means ± S.D. from n = 9–13 rats. LV EF = left ventricular ejection fraction (determined by four-chamber 
longitudinal view); RV FAC = right ventricular fractional area change (determined by four-chamber view).
Table 4. 
Biventricular function determined by echocardiography.
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there were significant differences in the expression between both ventricles. In 
the LV, four genes were significantly downregulated: GATA4, VEGF, eNOS, and 
MHC-α. VEGF, eNOS, and MHC-α genes contain a GATA4 promoter region. As 
expected, GATA4 expression correlated significantly with that of VEGF, eNOS, 
and MHC-α (Figure 3). Only two genes were upregulated (MMP12, Mef2c) at that 
time point. As MMP12 is a neutrophil-specific elastase, its strong expression in LV 
may indicate leukocyte infiltration into the LV during initial tissue repair. In the 
RV, only one gene was significantly affected by myocardial ischemia/reperfusion 
at that time (NCX). Figure 4 shows the relative expression of all genes including 
those that were either up- or downregulated but without reaching the level of sig-
nificance. At day 1, there is more variability and, therefore, more transcriptional 
adaptation in LV compared to RV. In the LV, the strongest downregulation that was 
not yet significant (>0.05) was found for laminin (again correlated with GATA4; 
Figure 3). The strongest upregulation that was not yet significant was found for 
MMP9. However, lack of statistical significance for laminin and MMP9 indicates a 
high interindividual variability. In the RV, ANP and Nkx.2a were strongly upregu-
lated and collagen-3 was strongly downregulated but yet not significant.
Figure 2. 
Time-dependent induction gene regulation in both ventricles. Note that the number of genes differentially 
regulated (cutoff p < 0.05) is increased in RV after 3 days.
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At day 3, there were many genes significantly upregulated in both ventricles such 
as BNP, MHC-α, SERCA2a, phospholamban, NCX, and VEGF. ANP and PGC-1α 
were also significantly upregulated but in both ventricles. However, the individual 
variability in RV was strong for these genes so that the level of induction did not 
reach the level of significance. An exception from the coregulation of genes between 
both ventricles is the transcription factor Nkx.2a. Nkx2a was upregulated in the LV 
but beyond the level of detection in the RV. At day 3, only two genes were downregu-
lated in the LV. These are RAMP-2, that was similarly downregulated in the RV and 
vWF that was slightly reduced in the RV. In addition to the aforementioned genes, six 
genes were specifically upregulated in the RV that were not induced in the LV. These 
were decorin, collagen-3, eNOS, RAMP-3, MMP12, and Nrf-1. The increased expres-
sion of most of these genes is indicated in the plot shown in Figure 4.
At day 7, the expression of most genes induced at early time points was normal-
ized again. However, at that time point, many genes were significantly downregu-
lated. In the LV, this holds for NCX, intermedin, PGC-1α, vWF, and VE-cadherin. 
Only VE-cadherin and intermedin were also downregulated in the RV; although 
due to the high individual variability of the RV, this does not reach the level of 
significance. Only biglycan was induced in the LV at this time point. The gene 
expression profile of the RV differed significantly from that of the LV at this time 
point. SERCA2a and NCX were still strongly induced. TGF-β1, bax, bcl-2, RAMP-1, 
RAMP-2, iNOS, Nrf-1, and CXCR4 were all significantly downregulated. The level 
of regulation strongly increased the level of regulation of these genes in the left 
ventricle. Figure 4 summarizes the expression of all genes at that time point.
Figure 3. 
Correlation between GATA4 expression and that of GATA4-dependent regulated genes.
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At day 120, 6 out of 36 genes under investigation were downregulated in the 
LV. These were decorin, RAMP-1, MMP9, MMP12, GATA4, and vWF. Among 
them, only GATA4 and vWF were not similarly downregulated in the RV. Elastin, 
fibronectin, bax, and Nkx.2a were specifically downregulated in the RV. Except 
for Nkx.2a, similar changes (although not significant) were also seen in the 
LV. The expression of SERCA2a was induced in the RV at that time but not in 
the LV. Overall, a stronger transcription adaptation is seen in the RV at that time 
(Figure 4).
Figure 4. 
Profile of gene expression at days 1, 3, 7, and 120 in both ventricles. Upregulated genes are on the right side. 
Above the horizontal bar differences are below p < 0.05.
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4. Discussion
This study investigated transcriptional adaptation in LV and RV following 
ischemia/reperfusion in vivo up to 120 days. A higher gene expression level has 
been attributed to better postinfarct adaptation in female versus male mice [11]. 
Here, differences were found between both ventricles in the very early phase 
after ischemia/reperfusion. A significant downregulation of the transcription 
factor GATA-4 was found specifically in the LV 24 h after reperfusion confirming 
similar findings after 2 h [11]. According to this observation, the expressions of 
GATA4-dependent genes (MHC-α, eNOS, and VEGF) were also downregulated. 
GATA-4 can exert cell survival signaling in cardiac myocytes and delivery of 
GATA-4 locally to the infarct border zone induces multiple local effects resulting 
in beneficial remodeling [12, 13]. Regardless of these initial differences, similar 
changes, mainly induction of gene expression, were found in both ventricles after 
3 days. In both ventricles, repression of cardiac gene expression was more promi-
nent rather than induction at later time points, specifically after 4 months. At that 
time point, the expression profile significantly differed between both ventricles 
with a more adaptive phenotype in the RV. Again, at this later time point, reduced 
expression of GATA4 seems to account for some of the differentially downregu-
lated genes in the LV. In summary, this study highlights the differential expression 
of GATA4 in LV and RV after successful reperfusion and correlates the expression 
of GATA4 with main differences in molecular adaptation between both ventricles. 
Regardless of the different molecular adaptation, LV and RV developed a drop of 
function although the infarct area and inflammation was specifically located at 
the left ventricle.
The cardiac ventricle is able to respond to ischemic stress with changes in 
steady-state mRNA levels within 24 h. In principle, steady-state levels of mRNA are 
the sum of mRNA formation and degradation and the quantification of steady-state 
levels does not necessarily identify mechanisms that cause these changes. However, 
in the current study, the main changes in ventricular expression that occurred 
within 24 h in the LV corresponded to genes that are known to obtain a GATA-4 
promoter responsive element. Please note that only the LV is exposed to ischemia/
reperfusion. Moreover, GATA-4 itself was also downregulated. It should be noted 
that within the first few hours after the ischemic event, transcriptional changes 
were mainly present in the LV.
The response of the heart to LV ischemia and reperfusion significantly differed at 
day 3. At that time, strong molecular adaptations were obtained in both ventricles. In 
most cases, these were linked to an upregulation of genes indicating an active adapta-
tion to the postischemic stress. Interestingly, most genes that were upregulated in the 
LV were also regulated in the RV. An exception to this rule was Nkx.2a. This cardiac-
specific transcription factor was below the level of detection in the RV but induced in 
the LV, probably indicating an active regenerative process. This may indicate cardiac 
differentiation of cells infiltrated into the infarct-affected ventricle (possibly circulat-
ing stem cells), or a cardiac differentiation of cells that were located in the LV and that 
still have a potential to differentiate (cardiac progenitor cells). Alternatively, it may 
indicate an active repair process of terminally differentiated cardiomyocytes (hyper-
trophy). However, the more important finding was the observation that a couple of 
genes were specifically upregulated in the RV that are not induced in the LV. As such 
decorin, an endogen inhibitor of the profibrotic cytokine TGF-β1, eNOS, increasing 
the bioavailability of nitric oxide, and Nrf-1, improving mitochondrial biogenesis, 
were identified. Each of these factors is a marker of compensatory hypertrophy.
One week after the ischemic event, the initial activation of gene transcrip-
tion is normalized and replaced by downregulation of many genes in LV and 
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RV. Interestingly among them are endothelial cell markers and genes linked to 
cardiac metabolism. Thus, the molecular adaptation switches into a profile of 
maladaptation. In concert with this view, biglycan, a factor that favors fibrosis, was 
induced in the LV. In the RV, the expression of profibrotic genes was downregulated 
as well as the expression of inflammatory markers. Again, the molecular adaptation 
of the RV seems to be more favorable than that of the LV.
Four months after the ischemic event, the cardiac function was reduced in both 
ventricles. At that time, decorin was downregulated in both ventricles. Moreover, 
the RV was characterized by downregulation of elastin and fibronectin. Both 
molecules are required for a proper cardiac function. In summary, although the 
molecular adaptation of the RV to LV myocardial infarction differs from that of  
the LV, the corresponding molecular adaptation of the RV leads to dysfunction of 
the RV as well.
In this study, we analyzed also the expression of intermedin and the receptor 
activation modifier proteins (RAMP). They have been analyzed with respect to 
cardiac regulation in the context of pressure-induced hypertrophy but data on the 
expression in ischemia and reperfusion are lacking. Intermedin (=adrenomedul-
lin-2) potentially stabilized cardiac function by binding to CGRP receptors that 
are linked to RAMP-1, -2, or -3. This study shows a downregulation of intermedin 
in the RV at day 3 and in the LV at day 7. Thus, it is differentially regulated during 
the subsequent molecular adaptation after ischemia/reperfusion but not as a direct 
response to the ischemic event itself. Significant downregulation of RAMP-2 and 
RAMP-1 days after myocardial infarction in both ventricles (RAMP-2) and specifi-
cally in the RV (RAMP-1) suggests an impairment of receptor signaling during 
CGRP-receptors during the subsequent remodeling process. As the development 
of cardiac dysfunction occurred in both ventricles within 4 months, this observa-
tion requires future work because this may be a likely candidate for the subsequent 
development of heart failure.
Finally, it should be mentioned that this study has of course some limitations. 
Firstly, data are restricted to genes which mRNA steady-state levels are different 
between sham and ischemia/reperfusion at a p value of 0.05. This does not exclude 
the possibility that genes that are strongly regulated but below a p value of 0.05 
due to a higher individual variation are not relevant for the molecular adaptation. 
Secondly, the level of significance is a variable of the n number of animals that are 
investigated. Here, we used eight rats per group. A lower n reduces the number of 
genes identified as significantly regulated. However, these limitations are counter-
balanced by the quantitative real-time RT-PCR protocol and even more important 
by the high number of genes under investigation and the analysis of groups of genes 
linked to specific adaptations (i.e., linked to fibrosis, apoptosis, etc.). This allows a 
more general view on the adaptation process.
In conclusion, the study identifies a time-dependent difference in the response 
of LV and RV to STEMI. In the early phase of LV remodeling, GATA-4-dependent 
downregulation was dominant. The novel and important finding from this study 
is, however, that a delayed but significant molecular adaptation of the RV. This RV 
adaptation in the absence of necrosis seems to be more adaptive but still not suffi-
cient to preserve the function. The regulation of RAMP-2 in both ventricles may be 
one candidate for future research.
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